Skip to main content

Advertisement

SpringerLink
Log in

The effects of recombinant human TSH on bone turnover in patients after thyroidectomy

  • Original Article
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Thyrotropin receptors are expressed in several extrathyroidal tissues including bone. We investigated whether the increase of thyroid-stimulating hormone (TSH) levels, under stable thyroid hormone levels, affects the bone markers. Thirty-two postmenopausal women, with papillary thyroid carcinoma, previously treated with near-total thyroidectomy and I131 remnant ablation underwent routine evaluation for residual disease by using injections of recombinant human TSH (rhTSH) without withdrawal from thyroxine therapy. Changes in TSH levels and various serum and urine markers of bone metabolism were followed before and 1, 2, 5, and 7 days after the rhTSH injections. A transient, significant decrease in serum calcium and urinary excretion of C- and N-terminal telopeptides of type I collagen was observed after the injections of rhTSH. Serum parathyroid hormone (PTH) started to rise along with TSH, but a significant increase of PTH was only reached on Day 5 when the TSH concentration had fallen more than 80% of the peak value. Bone alkaline phosphatase and osteocalcin did not show any significant change over time. There was no significant correlation between TSH concentration and the various parameters we measured. The study provides evidence that rhTSH produces a transient inhibition of bone resorption, as well as an attenuation of osteoblast response in spite of the PTH activation. Additional studies are needed to resolve the mechanisms by which TSH alters the response of the bone cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mosekilde L, Eriksen EF, Charles P (1990) Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19:35–63

    CAS  PubMed  Google Scholar 

  2. Basset DJ, Williams G (2003) The molecular actions of thyroid hormone in bone. TRENDS Endocrinol Metab 14:356–364

    Article  Google Scholar 

  3. Mundy GR, Shapiro JL, Bandelin JG, Canalis EM, Raisz LG (1976) Direct stimulation of bone resorption by thyroid hormones. J Clin Invest 58:529–534

    Article  CAS  PubMed  Google Scholar 

  4. Ross DS (1994) Hyperthyroidism, thyroid hormone therapy, and bone. Thyroid 4:143–144

    Article  Google Scholar 

  5. Siddiqi A, Monson J, Wood D, Besser G, Burrin J (1999) Serum cytokines in thyrotoxicosis. J Clin Endocrinol Metab 84:435–439

    Article  CAS  PubMed  Google Scholar 

  6. Akalin A, Colak Ö, Alatast Ö, Efe B (2002) Bone remodelling markers and serum cytokines in patients with hyperthyroidism. Clin Endocrinol 57:125–129

    Article  CAS  Google Scholar 

  7. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2–12

    Article  CAS  PubMed  Google Scholar 

  8. Coindre JM, David JP, Riviere L, Goussot JF, Roger P, de Marscarel A et al (1986) Bone loss in hypothyroidism with hormone replacement: a histomorphometric study. Arch Intern Med 146:48–53

    Article  CAS  PubMed  Google Scholar 

  9. Krolner B, Jorgensen JV, Nielsen SP (1983) Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormones and antithyroid treatment. Clin Endocrinol (Oxf) 18:439–446

    Article  CAS  Google Scholar 

  10. Davies T, Russel M, Latif R (2002) The TSH receptor reveals itself. J Clin Invest 110:161–164

    CAS  PubMed  Google Scholar 

  11. Inoue M, Tawata M, Yokomori N, Endo T, Onaya T (1998) Expression of thyrotropin receptor on clonal osteoclast-like rat osteosarcoma cells. Thyroid 8:1059–1064

    Article  CAS  PubMed  Google Scholar 

  12. Abe E, Marians RC, Yu W, Wu XB, Ando T, Li Y, Iqbal J et al (2003) TSH is a negative regulator of skeletal remodelling. Cell 115:151–162

    Article  CAS  PubMed  Google Scholar 

  13. Tsai JA, Janson A, Bucht E, Kindmark H, Marcus C, Stark A, Zemack HR, Torring O (2004) Weak evidence of thyrotropin receptors in primary cultures of human osteoblast-like cells. Calcif Tissue Int 74:486–491

    Article  CAS  PubMed  Google Scholar 

  14. Bauer DC, Nevitt MC, Ettinger B, Stone K (1997) Low thyrotropin levels are not associated with bone loss in older women: a prospective study. J Clin Endocrinol Metab 82:2931–2932

    Article  CAS  PubMed  Google Scholar 

  15. Mazzioti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Biondi B et al (2005) Recombinant TSH modulates in vivo C-telopeptides of type-I collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. J Bone Miner Res 20:480–486

    Article  Google Scholar 

  16. Martini G, Gennari L, De Paola V, Pilli T, Salvadon S, Merlotti D et al (2008) The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels. Thyroid 18:455–460

    Article  CAS  PubMed  Google Scholar 

  17. Giusti M, Cecoli F, Ghiara C, Rubinacci A, Villa I, Cavallero D et al (2007) Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kB ligand in patients under evaluation for differentiated thyroid carcinoma. Hormones (Athens) 6:304–313

    Google Scholar 

  18. Sampath KT, Simic P, Sendak R, Draca N, Schiabi S, McPherson J et al (2005) Systemic administration of thyroid stimulating hormone (TSH) prevents and restores bone loss in rats following ovariectomy. J Bone Miner Res 20:S415

    Google Scholar 

  19. Sellitti DF, Akamizu T, Doi SQ, Kim GH, Kariyil JT, Kopvhik JJ et al (2000) Renal expression of two “thyroid-specific” genes: thyrotropin receptor and thyroglobulin. Thyroid 8:235–243

    CAS  Google Scholar 

  20. Dutton CM, Joba W, Spitzweg C, Heufelder AE, Bahn RS (1997) Thyrotropin receptor expression in adrenal, kidney, and thymus. Thyroid 7:879–884

    Article  CAS  PubMed  Google Scholar 

  21. Hase H, Ando T, Eldeiry L, Brebene A, Peng Y, Liu L et al (2006) TNFalpha mediates the skeletal effects of thyroid-stimulating hormone. Proc Natl Acad Sci USA 103:12849–12854

    Article  CAS  PubMed  Google Scholar 

  22. Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115–137

    Article  CAS  PubMed  Google Scholar 

  23. Kaneki H, Guo R, Chen D, Yao Z, Schwarz EM, Zhang YE et al (2005) Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J Biol Chem 281:4326–4333

    Article  PubMed  Google Scholar 

  24. Cooper DS, Kaplan MM, Ridgway EC, Maloof F, Daniels GH (1979) Alkaline phosphatase isoenzyme patterns in hyperthyroidism. Ann Intern Med 90:164–168

    CAS  PubMed  Google Scholar 

  25. Pantazi H, Papapetrou PD (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 85:1099–1106

    Article  CAS  PubMed  Google Scholar 

  26. Siddiqi A, Burrin JM, Noonan K, James I, Wood DF, Price CP et al (1997) A longitudinal study of markers of bone turnover in Graves’ disease and their value in predicting bone mineral density. J Clin Endocrinol Metab 82:753–759

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 2nd Division of Endocrinology and Metabolism, Alexandra Hospital, Vas. Sofias and Lourou, 115 28, Athens, Greece

    Helen Karga, Garyphallia Papaioannou, Antonis Polymeris, Konstantinos Papamichael, Angeliki Karpouza, Elizabeth Samouilidou & Panayotis Papaioannou

Authors
  1. Helen Karga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Garyphallia Papaioannou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonis Polymeris
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Konstantinos Papamichael
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Angeliki Karpouza
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elizabeth Samouilidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Panayotis Papaioannou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Helen Karga.

About this article

Cite this article

Karga, H., Papaioannou, G., Polymeris, A. et al. The effects of recombinant human TSH on bone turnover in patients after thyroidectomy. J Bone Miner Metab 28, 35–41 (2010). https://doi.org/10.1007/s00774-009-0098-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-009-0098-y

Keywords

Search

Navigation